{"transactions":[{"id":695920,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-05T21:07:21.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":6551,"price":1.65,"value":10809.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired shares in the second closing of a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, as amended on August 3, 2026, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share."}],"balance_after":284968,"source":{"system":"sec-edgar","filing":"0001628280-26-053505","document":"wk-form4_1785964039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000162828026053505/wk-form4_1785964039.xml","form_type":"4"}},{"id":766257,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-05-22T20:31:04.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option vested upon grant with the remaining shares vesting ratably over thirty-six months, subject to continued service on the Board."}],"balance_after":11000,"derivative":{"exercise_price":10.77,"expiration_date":"2036-05-20","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-26-065763","document":"tm2615475-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000110465926065763/tm2615475-3_4seq1.xml","form_type":"4"}},{"id":766256,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-05-22T20:31:04.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full on May 20, 2027, subject to continued service on the Board."}],"balance_after":5500,"derivative":{"exercise_price":10.77,"expiration_date":"2036-05-20","underlying":"Common Shares","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001104659-26-065763","document":"tm2615475-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000110465926065763/tm2615475-3_4seq1.xml","form_type":"4"}},{"id":816919,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:46:22.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":580000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant."}],"balance_after":580000,"derivative":{"exercise_price":4.46,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":580000},"source":{"system":"sec-edgar","filing":"0001927058-26-000002","document":"wk-form4_1775249179.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000192705826000002/wk-form4_1775249179.xml","form_type":"4"}},{"id":961156,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-22T22:41:14.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option has a vesting start date of December 1, 2025 and vests as to one third (33.33%) of the shares subject to the option on the first anniversary of the vesting start date and as to the remaining shares in equal monthly installments over 24 months thereafter, subject to continued service."}],"balance_after":425000,"derivative":{"exercise_price":6.01,"expiration_date":"2035-12-10","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001927058-25-000004","document":"wk-form4_1766443271.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000192705825000004/wk-form4_1766443271.xml","form_type":"4"}},{"id":1043009,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T20:23:42.000Z","date":"2025-09-11","kind":"purchase","planned":false,"acquired":true,"shares":6060,"price":1.65,"value":9999.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 11, 2025, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share."}],"balance_after":278417,"source":{"system":"sec-edgar","filing":"0001927058-25-000002","document":"wk-form4_1757622219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000192705825000002/wk-form4_1757622219.xml","form_type":"4"}},{"id":1109999,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-06-16T21:23:07.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the earlier of the first anniversary of the Grant Date and June 12, 2026, subject to continued service on the Board."}],"balance_after":20000,"derivative":{"exercise_price":0.5,"expiration_date":"2035-06-12","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001374339-25-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000137433925000006/primary_doc.xml","form_type":"4"}},{"id":1180159,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T20:06:02.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant."}],"balance_after":160000,"derivative":{"exercise_price":3.86,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001628280-25-016481","document":"wk-form4_1743710748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000162828025016481/wk-form4_1743710748.xml","form_type":"4"}},{"id":1386780,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Preferred Stock","published_at":"2024-10-15T21:45:11.000Z","date":"2024-10-15","kind":"exercise","planned":false,"acquired":false,"shares":6791,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":605},"source":{"system":"sec-edgar","filing":"0001104659-24-108699","document":"tm2426125-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000110465924108699/tm2426125-1_4seq1.xml","form_type":"4"}},{"id":1386779,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-15T21:45:11.000Z","date":"2024-10-15","kind":"exercise","planned":false,"acquired":true,"shares":605,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 15, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering."}],"balance_after":272357,"source":{"system":"sec-edgar","filing":"0001104659-24-108699","document":"tm2426125-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000110465924108699/tm2426125-1_4seq1.xml","form_type":"4"}},{"id":1390247,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":26284,"kind":"person","name":"Mandel-Brehm Josh","position":1,"cik":"0001927058","reported_name":"Mandel-Brehm Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-10-07T22:38:16.000Z","date":"2024-10-03","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares subject to this option vested on October 3, 2024, and the balance shall vest ratably over the following 24 months, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.11,"expiration_date":"2034-10-03","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-24-106767","document":"tm2425760-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927058/000110465924106767/tm2425760-2_4seq1.xml","form_type":"4"}}]}